Super-potent synthetic opioids called nitazenes are spreading across the U.S.
-
By
-
Jonathan Moens — Bellingcat
-
June 18, 2026
-
0 min
By
Jonathan Moens — Bellingcat
June 18, 2026
by Jonathan Moens — Bellingcat
June 18, 2026
In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.
May 27, 2026
Several FDA decisions across multiple specialties are expected this month.
May 29, 2026